GL1X · GenesisL1 explorer

Research workbench

Discovery of gdc-0980: a potent, selective, and orally available class I phosphatidylinositol 3-kinase (PI3K)/MAMMALIAN target of rapamycin (mtor) kinase inhibitor for the treatment of cancer

Analyse Discovery of gdc-0980: a potent, selective, and orally available class I… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3TL5
Type
protein
Length
845 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
EC
2.7.1.153
UniProt
P48736
Ligands
980
Pockets
15 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (EC 2.7.1.153)protein84544% helix, 17% strandP48736

Ligands and binding sites

  • 980 · (2S)-1-(4-{[2-(2-aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}piperazin-1-yl)-2-hydroxypropan-1-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

15 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111290.820.8372empty
24830.680.7947980
33060.660.8133empty
41220.630.8722empty
53250.610.7845empty

Compared structures

  • 3TL5 · Discovery of GDC-0980: a Potent, Selective, and Orally Available Class I… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.